Inactive Instrument

News Iconovo AB (publ) Nasdaq Stockholm

Equities

SE0010868943

Summary

Unlock all the news: Be the first to know and act before the market!

ICONOVO AB PUBLISHES THE ANNUAL REPORT 2023 IN ENGLISH	24/05	AQ
BioStock: Iconovo initiates development of inhaled obesity treatment	21/05	AQ
Iconovo files patent application for inhaled GLP-1 products and initiates development of new obesity treatments	15/05	AQ
Iconovo AB Files Patent Application for Inhaled GLP-1 Products and Initiates Development of New Obesity Treatments	15/05	CI
Sweden's Iconovo to Receive Chinese Patent for ICOres Inhaler	06/05	MT
Iconovo receives patent protection for ICOres® in China	06/05	AQ
Iconovo AB Receives Patent Protection for Icores in China	06/05	CI
Iconovo Q1 - Solid quarter with a near-term catalyst on the horizon	26/04	AQ
Iconovo AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Iconovo to present positive data from a feasibility study on Nanofitins® in ICOone®	11/03	AQ
Iconovo AB and Affilogic to Present Positive Data from a Feasibility Study on Nanofitins in ICOone	11/03	CI
Iconovo receives grant of SEK 680,000 from Innowwide for market efforts in South Korea	05/03	AQ
Iconovo Q4 - Aligned with our expectations and a directed issue announcement	19/02	AQ
Iconovo AB Reports Earnings Results for the Full Year Ended December 31, 2023	16/02	CI
Iconovo AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	16/02	CI
Iconovo carries out a directed share issue of SEK 33.3 million, partly subject to subsequent approval by the Extraordinary General Meeting, and brings forward the publication of the year-end report	16/02	AQ
Iconovo signs additional contract with Kiox Pharma for the development of a new inhalable treatment for interstitial lung disease	07/02	AQ
Iconovo AB Signs Additional Contract with Kiox Pharma for the Development of A New Inhalable Treatment for Interstitial Lung Disease	07/02	CI
Iconovo launches improved versions of nasal ICOone® inhalers	06/02	AQ
Iconovo AB Launches Improved Versions of Nasal ICOone Inhalers	06/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Iconovo AB (publ) Nasdaq Stockholm

Equities

SE0010868943

Summary

Filters